IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $43,116,000 | -33.7% | 3,021,466 | -3.2% | 2.51% | -27.7% |
Q3 2018 | $64,985,000 | -12.0% | 3,119,778 | 0.0% | 3.47% | -27.5% |
Q2 2018 | $73,845,000 | +257.2% | 3,119,778 | +111.0% | 4.79% | +156.6% |
Q3 2017 | $20,673,000 | +466.4% | 1,478,742 | +47.9% | 1.87% | +406.2% |
Q2 2014 | $3,650,000 | – | 1,000,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,850,000 | $12,513,000 | 4.70% |
Avoro Capital Advisors LLC | 7,344,177 | $23,869,000 | 4.19% |
NEXTHERA CAPITAL LP | 1,263,276 | $4,106,000 | 2.52% |
Opaleye Management Inc. | 1,200,000 | $3,900,000 | 2.04% |
First Light Asset Management, LLC | 992,867 | $3,227,000 | 1.39% |
DAFNA Capital Management LLC | 566,796 | $1,842,000 | 1.28% |
Ghost Tree Capital, LLC | 2,000,000 | $6,500,000 | 1.05% |
Iguana Healthcare Management, LLC | 600,000 | $1,950,000 | 0.35% |
PURA VIDA INVESTMENTS, LLC | 319,565 | $1,039,000 | 0.32% |
J. Goldman & Co LP | 1,696,699 | $5,514,000 | 0.31% |